SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA issues EIR for Marksans Pharma’s Goa manufacturing facility

20 Aug 2024 Evaluate

The USFDA has issued an Establishment Inspection Report (EIR) for the manufacturing facility of Marksans Pharma located at Verna Industrial estate, Verna, Goa, India.  The inspection has now been successfully closed by the USFDA. USFDA has determined that the inspection classification of this facility is Voluntary Action Indicated (VAI). The inspection was conducted by the USFDA at the manufacturing facility of the Company from April 09, 2024 to April 17, 2024. 

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.


Marksans Pharma Share Price

260.20 -1.10 (-0.42%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: